[1] Wysowski D K, Swartz L. Adverse Drug Event Surveillance and Drug Withdrawals in the United States, 1969-2002: The Importance of Reporting Suspected Reactions[J]. Arch Intern Med, 2005, 165(12):1363-1369. [2] Harpaz R, Dumouchel W, Shah N H, et al. Novel Data-Mining Methodologies for Adverse Drug Event Discovery and Analysis[J]. Clin Pharmacol Ther, 2012, 91(6):1010-1021. [3] 邓凤云. 187例儿童严重药品不良反应/事件相关因素分析[J]. 儿科药学杂志, 2015, 21(8):35-38. [4] 陈建玉, 张惠霞. 从清开灵ADR/ADE报告和说明书分析看儿童安全用药[J]. 中国药物警戒, 2010, 7(7):417-420. [5] Classen D C, Resar R, Griffin F, et al. ‘Global trigger tool’shows that adverse events in hospitals may be ten times greater than previously measured[J]. Health Aff, 2011, 30(4):581-589. [6] 季欢欢, 宋林, 肖剑文,等. 全面触发工具用于住院儿童药品不良事件主动监测[J]. 中国新药与临床杂志, 2016, 35(9):674-679. [7] Karch F E, Lasagna L. Toward the operational identification of adverse drug reactions[J]. Clin Pharmacol Ther, 1977,21(3):247-254. [8] Harpaz R, Perez H, Chase H S, et al. Biclustering of Adverse Drug Events in the FDA’s Spontaneous Reporting System[J]. Clin Pharmacol Ther, 2011, 89(2):243-250. [9] Vermeer N S, Straus S M, Mantelteeuwisse A K, et al. Traceability of biopharmaceuticals in spontaneous reporting systems: a cross-sectional study in the FDA Adverse Event Reporting System (FAERS) and EudraVigilance databases[J]. Drug Saf, 2013, 36(8):617-625. [10] Marja Härkänen, Marjo Kervinen, Jouni Ahonen , et al. Patient-specific risk factors of adverse drug events in adult inpatients - evidence detected using the Global Trigger Tool method[J]. J Clin Nurs, 2015, 24(3-4):582-591. [11] Sam A T, Lian J L, Parasuraman S. A retrospective study on the incidences of adverse drug events and analysis of the contributing trigger factors[J]. J Basic Clin Pharm, 2015, 6(2):64-68. [12] 魏晶,谢雁鸣.药品不良反应报告因果关系评价方法概述[J].中国中药杂志,2012,37 (18):2744-7. [13] Eshetie T C, Hailemeskel B, Mekonnen N, et al. Adverse drug events in hospitalized children at Ethiopian University Hospital: a prospective observational study[J]. BMC Pediatr, 2015, 15(1):83. [14] You M A, Nam S M, Son Y J. Parental Experiences of Medication Administration to Children at Home and Understanding of Adverse Drug Events[J]. J Nurs Res, 2015, 23(3):189. [15] 王晓瑜, 程能能. 2004—2012年上海地区儿童药品不良事件报告分析[J]. 中国新药与临床杂志, 2014,7(10):773-776. [16] 李宏力, 程能能, 李熠,等. 自发呈报系统中已知ADR报告对信号检出的影响[J]. 中国药物警戒, 2010, 7(11):667-669. [17] Takata G S, Taketomo C K, Waite S. Characteristics of medication errors and adverse drug events in hospitals participating in the California Pediatric Patient Safety Initiative[J]. Am J Health Syst Pharm, 2008, 65(21):2036-2044. [18] Kirkendall E S, Kloppenborg E, Papp J, et al. Measuring adverse events and levels of harm in pediatric inpatients with the Global Trigger Tool[J]. Pediatrics, 2012, 130(5):1206-1214. |